 NEW YORK, Feb. 18, 2021 GLOBE NEWSWIRE -- GBS Inc. Nasdaq: GBS, a life sciences company that develops non-invasive, real-time point of care POC diagnostic tests for patients and their primary health practitioners, today announced the execution of a sponsored research agreement with Johns Hopkins Bloomberg School of Public Health to accelerate development of next-generation saliva-based diagnostic tests. 